Hamna Shahnawaz

586 total citations · 2 hit papers
5 papers, 328 citations indexed

About

Hamna Shahnawaz is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Hamna Shahnawaz has authored 5 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Immunology. Recurrent topics in Hamna Shahnawaz's work include RNA Interference and Gene Delivery (4 papers), Viral gastroenteritis research and epidemiology (1 paper) and Viral Infections and Immunology Research (1 paper). Hamna Shahnawaz is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Viral gastroenteritis research and epidemiology (1 paper) and Viral Infections and Immunology Research (1 paper). Hamna Shahnawaz collaborates with scholars based in United States. Hamna Shahnawaz's co-authors include Drew Weissman, Barbara L. Mui, Amir Yadegari, Hamideh Parhiz, Vladimir R. Muzykantov, Tyler E. Papp, Vladimir V. Shuvaev, Ying K. Tam, Dorottya Laczkó and Mohamad‐Gabriel Alameh and has published in prestigious journals such as Journal of the American Chemical Society, Molecular Therapy and Molecular Therapy — Nucleic Acids.

In The Last Decade

Hamna Shahnawaz

5 papers receiving 322 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

2021 183 citations István Tombácz, Dorottya Laczkó et al. Molecular Therapy profile →
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA

2021 123 citations Dapeng Zhang, Elena N. Atochina‐Vasserman et al. Journal of the American Chemical Society profile →

Peers

Countries citing papers authored by Hamna Shahnawaz

Since Specialization

Citations

This map shows the geographic impact of Hamna Shahnawaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamna Shahnawaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamna Shahnawaz more than expected).

Fields of papers citing papers by Hamna Shahnawaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamna Shahnawaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamna Shahnawaz. The network helps show where Hamna Shahnawaz may publish in the future.

Co-authorship network of co-authors of Hamna Shahnawaz

This figure shows the co-authorship network connecting the top 25 collaborators of Hamna Shahnawaz. A scholar is included among the top collaborators of Hamna Shahnawaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamna Shahnawaz. Hamna Shahnawaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery 2025 ·Molecular Therapy ·Tyler E. Papp, (unknown), Hamna Shahnawaz, (unknown), Laura Breda, Amir Yadegari, J. K. Steward, (unknown), Qin Li, Barbara L. Mui, Ying K. Tam, Drew Weissman, Stefano Rivella, Vladimir V. Shuvaev, Vladimir R. Muzykantov, (unknown)	7
2	Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection 2024 ·npj Vaccines ·Elena N. Atochina‐Vasserman, Lisa C. Lindesmith, Carmen Mirabelli, Nathan Ona, Erin K. Reagan, Paul D. Brewer-Jensen, (unknown), Hamna Shahnawaz, (unknown), (unknown), Michael L. Mallory, Mark R. Zweigart, (unknown), Barbara L. Mui, Ying K. Tam, Christiane E. Wobus, Ralph S. Baric, Drew Weissman	4
3	Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system 2024 ·Molecular Therapy — Nucleic Acids ·Hamideh Parhiz, Vladimir V. Shuvaev, Qin Li, Tyler E. Papp, (unknown), (unknown), Amir Yadegari, Hamna Shahnawaz, Sean C. Semple, Barbara L. Mui, Drew Weissman, Vladimir R. Muzykantov, Patrick M. Glassman	11
4	Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs breakdown → 2021 ·Molecular Therapy ·István Tombácz, Dorottya Laczkó, Hamna Shahnawaz, Hiromi Muramatsu, (unknown), Amir Yadegari, Tyler E. Papp, Mohamad‐Gabriel Alameh, Vladimir V. Shuvaev, Barbara L. Mui, Ying K. Tam, Vladimir R. Muzykantov, Norbert Pardi, Drew Weissman, Hamideh Parhiz	183
5	One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA breakdown → 2021 ·Journal of the American Chemical Society ·Dapeng Zhang, Elena N. Atochina‐Vasserman, Devendra S. Maurya, Ning Huang, Qi Xiao, Nathan Ona, Matthew Liu, Hamna Shahnawaz, Houping Ni, (unknown), Margaret M. Billingsley, Darrin J. Pochan, Michael J. Mitchell, Drew Weissman, Virgil Percec	123

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact